Literature DB >> 21715330

Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein.

Li Ou1, Antonio M Ferreira, Steve Otieno, Limin Xiao, Donald Bashford, Richard W Kriwacki.   

Abstract

p27(Kip1) (p27), an intrinsically disordered protein, regulates the various Cdk/cyclin complexes that control cell cycle progression. The kinase inhibitory domain of p27 contains a cyclin-binding subdomain (D1), a Cdk-binding subdomain (D2), and a linker helix subdomain that connects D1 and D2. Here, we report that, despite extensive sequence conservation between Cdk4/cyclin D1 (hereafter Cdk4/cyclin D) and Cdk2/cyclin A, the thermodynamic details describing how the individual p27 subdomains contribute to equally high affinity binding to these two Cdk/cyclin complexes are strikingly different. Differences in enthalpy/entropy compensation revealed that the D2 subdomain of p27 folds incompletely when binding Cdk4/cyclin D versus Cdk2/cyclin A. Incomplete binding-induced folding exposes tyrosine 88 of p27 for phosphorylation by the nonreceptor tyrosine kinase Abl. Importantly, tyrosine phosphorylation (of p27) relieves Cdk inhibition by p27, enabling cell cycle entry. Furthermore, the interaction between a conserved hydrophobic patch on cyclin D and subdomain D1 is much weaker than that with cyclin A; consequently, a construct containing subdomains D1 and LH (p27-D1LH) does not inhibit substrate binding to Cdk4/cyclin D as it does to Cdk2/cyclin A. Our results provide a mechanism by which Cdk4 (within the p27/Cdk4/cyclin D complex) is poised to be activated by extrinsic mitogenic signals that impinge upon p27 at the earliest stage of cell division. More broadly, our results further illustrate the regulatory versatility of intrinsically disordered proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715330      PMCID: PMC3191053          DOI: 10.1074/jbc.M111.244095

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins.

Authors:  P Zhou; A A Lugovskoy; G Wagner
Journal:  J Biomol NMR       Date:  2001-05       Impact factor: 2.835

2.  How viruses hijack cell regulation.

Authors:  Norman E Davey; Gilles Travé; Toby J Gibson
Journal:  Trends Biochem Sci       Date:  2010-12-09       Impact factor: 13.807

3.  p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.

Authors:  Isabel Chu; Jun Sun; Angel Arnaout; Harriette Kahn; Wedad Hanna; Steven Narod; Ping Sun; Cheng-Keat Tan; Ludger Hengst; Joyce Slingerland
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

4.  Using AutoDock for ligand-receptor docking.

Authors:  Garrett M Morris; Ruth Huey; Arthur J Olson
Journal:  Curr Protoc Bioinformatics       Date:  2008-12

5.  Crystal structure of human CDK4 in complex with a D-type cyclin.

Authors:  Philip J Day; Anne Cleasby; Ian J Tickle; Marc O'Reilly; Joe E Coyle; Finn P Holding; Rachel L McMenamin; Jeff Yon; Rajiv Chopra; Christoph Lengauer; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

6.  A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.

Authors:  W Pan; S Cox; R H Hoess; R H Grafström
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

7.  Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements.

Authors:  Shu Liu; Joshua K Bolger; Lindsay O Kirkland; Padmavathy N Premnath; Campbell McInnes
Journal:  ACS Chem Biol       Date:  2010-10-14       Impact factor: 5.100

8.  Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein.

Authors:  H M Chan; L Smith; N B La Thangue
Journal:  Oncogene       Date:  2001-09-27       Impact factor: 9.867

9.  Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity.

Authors:  Melissa K James; Arpita Ray; Dina Leznova; Stacy W Blain
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 5.069

10.  Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21.

Authors:  Yuefeng Wang; John C Fisher; Rose Mathew; Li Ou; Steve Otieno; Jack Sublet; Limin Xiao; Jianhan Chen; Martine F Roussel; Richard W Kriwacki
Journal:  Nat Chem Biol       Date:  2011-02-27       Impact factor: 15.040

View more
  19 in total

1.  Mechanism of cell cycle entry mediated by the intrinsically disordered protein p27(Kip1).

Authors:  Li Ou; M Brett Waddell; Richard W Kriwacki
Journal:  ACS Chem Biol       Date:  2012-02-03       Impact factor: 5.100

2.  PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.

Authors:  Sujie Ni; Lingling Chen; Mei Li; Weijuan Zhao; Xiaohang Shan; Miaomiao Wu; Jialin Cheng; Li Liang; Yayun Wang; Wenyan Jiang; Jianguo Zhang; Runzhou Ni
Journal:  Tumour Biol       Date:  2016-08-01

3.  Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

Authors:  Stephan C Jahn; Mary E Law; Patrick E Corsino; Thomas C Rowe; Bradley J Davis; Brian K Law
Journal:  Biochemistry       Date:  2013-05-09       Impact factor: 3.162

Review 4.  Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications.

Authors:  Alaji Bah; Julie D Forman-Kay
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

5.  Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation.

Authors:  Jacob B Swadling; Tobias Warnecke; Kyle L Morris; Alexis R Barr
Journal:  Biophys J       Date:  2022-05-25       Impact factor: 3.699

6.  Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma.

Authors:  Ellen Hukkelhoven; Yuhui Liu; Nancy Yeh; Daniel Ciznadija; Stacy W Blain; Andrew Koff
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

7.  p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes.

Authors:  Serena Orlando; Edurne Gallastegui; Arnaud Besson; Gabriel Abril; Rosa Aligué; Maria Jesus Pujol; Oriol Bachs
Journal:  Nucleic Acids Res       Date:  2015-06-13       Impact factor: 16.971

8.  p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition.

Authors:  Keelan Z Guiley; Jack W Stevenson; Kevin Lou; Krister J Barkovich; Vishnu Kumarasamy; Tilini U Wijeratne; Katharine L Bunch; Sarvind Tripathi; Erik S Knudsen; Agnieszka K Witkiewicz; Kevan M Shokat; Seth M Rubin
Journal:  Science       Date:  2019-12-13       Impact factor: 47.728

9.  Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2.

Authors:  Lindsey R Pack; Leighton H Daigh; Mingyu Chung; Tobias Meyer
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

10.  Probing the role of nascent helicity in p27 function as a cell cycle regulator.

Authors:  Steve Otieno; Richard Kriwacki
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.